# Communicating Multiple Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

> **NCT07110597** · NA · COMPLETED · sponsor: **London School of Economics and Political Science** · enrollment: 3184 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Statement communicating 1 source of uncertainty
- **OTHER:** Statements communicating 2 sources of uncertainties
- **OTHER:** Statements communicating 3 sources of uncertainties
- **OTHER:** Statements communicating 4 sources of uncertainties
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT07110597
- **Lead sponsor:** London School of Economics and Political Science
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-18
- **Primary completion:** 2025-07-26
- **Final completion:** 2025-07-26
- **Target enrollment:** 3184 (ACTUAL)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110597, "Communicating Multiple Uncertainties Associated With the Benefits and Risks of New Cancer Drugs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07110597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*